To provide Biosimilar
products around the world.
We specialize in developing biosimilar drugs. By providing our biosimilars to the medical fraternity, we are committed to contribute to the society and people by subsidizing medical spending to reduce financial burden of patients; while maintaining highest product quality
YL Biologics Limited is a joint venture between Yoshindo Inc. (headquartered in Toyama, Japan) and Lupin Limited (headquartered in Mumbai, India).
- Regarding the NDA filing for YLB217, a biosimilar product of long-acting erythropoiesis stimulating agent NespⓇ ”read more” link to press release PDF.
< Caution Notice >
Recently, there was a case in which someone posted an advertisement for recruitment under our name on the recruitment page of one job advertising company and attempted to steal personal information. Such a case has nothing to do with us. We are currently not recruiting new employees including through such an advertising company.
Corporate Headquarters: 12F, Hamacho Center Building2-31-1,
Nihonbashi Hamacho, Chuo-ku, Tokyo 103-0007